0001493152-24-008930.txt : 20240306
0001493152-24-008930.hdr.sgml : 20240306
20240306060628
ACCESSION NUMBER: 0001493152-24-008930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAHAREK JOHN P.
CENTRAL INDEX KEY: 0001632091
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 24724293
MAIL ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: Saharek John
DATE OF NAME CHANGE: 20150128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: HARROW HEALTH, INC.
DATE OF NAME CHANGE: 20181228
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
4
1
ownership.xml
X0508
4
2024-03-01
0
0001360214
HARROW, INC.
HROW
0001632091
SAHAREK JOHN P.
C/O HARROW, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
0
1
0
0
CEO of ImprimisRx
0
Common stock
2024-03-01
4
M
0
5000
8.75
A
254803
D
Stock Option (Right to Buy)
8.75
2024-03-01
4
M
0
5000
0
D
2024-03-03
Common Stock
5000
0
D
The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.
/s/ John P. Saharek
2024-03-06